Presentation of NAION in a Global Treatment Trial

Update Item Information
Identifier 20190318_nanos_sciplatform1_04_slides
Title Presentation of NAION in a Global Treatment Trial
Creator Mark Kupersmith; Neil Miller; Mays El-Dairi; Leonard Levin; Sharon Klier
Affiliation (MK) Neurology / Ophthalmology, Icahn School of Medicine at Mount Sinai & New York Eye and Ear Infirmary, New York, NY; (NM) Wilmer Institute of Johns Hopkins School of Medicine, Baltimore, MD; (MED) McGill University, QC, Canada; (LL) Duke University, Durham, NC; (SK) Quark Pharmaceutical, CA
Subject Optic Neuropathy; Vascular Disorders; Visual Fields
Description Knowledge of presenting features and systemic factors associated with acute NAION is based predominantly on retrospective reports and one prospective treatment trial, with only 258 participants. The Quark / NORDIC NAION treatment trial will recruit 800 participants and the features of the first 400 enrolled provides the largest prospectively uniformly collected dataset on NAION from multiple sites in 8 countries.
Date 2019-04
Language eng
Format application/pdf
Format Creation Microsoft PowerPoint
Type Text
Source 2019 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2018: Scientific Platform I
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s64x9vg3
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1453734
Reference URL https://collections.lib.utah.edu/ark:/87278/s64x9vg3
Back to Search Results